{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:29:13Z","timestamp":1791142153664,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"309","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Morphologie"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.morpho.2011.02.004","type":"journal-article","created":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T13:31:09Z","timestamp":1307539869000},"page":"65-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Bone metastasis: Histological changes and pathophysiological mechanisms in osteolytic or osteosclerotic localizations. A review"],"prefix":"10.1016","volume":"95","author":[{"given":"D.","family":"Chappard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bouvard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-F.","family":"Basl\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Audran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.morpho.2011.02.004_bib0005","first-page":"18","article-title":"Cancer and bone","volume":"19","author":"Guise","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.morpho.2011.02.004_bib0010","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02040","article-title":"Osteoblastic cells regulate the haematopoietic stem cell niche","volume":"425","author":"Calvi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.morpho.2011.02.004_bib0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.morpho.2011.02.004_bib0020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00003086-198511000-00027","article-title":"The pathomechanics of osteoporoses","author":"Frost","year":"1985","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.morpho.2011.02.004_bib0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF02556053","article-title":"Some ABCs of skeletal pathophysiology III: Bone balance and the delta B. BMU","volume":"45","author":"Frost","year":"1989","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.morpho.2011.02.004_bib0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00003086-199001000-00036","article-title":"Role of transforming growth factor-beta in bone remodeling","author":"Bonewald","year":"1990","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.morpho.2011.02.004_bib0035","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1091\/mbc.9.7.1903","article-title":"Osteoblastic responses to TGF-beta during bone remodeling","volume":"9","author":"Erlebacher","year":"1998","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.morpho.2011.02.004_bib0040","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/jrs.2272","article-title":"Fetuin and osteocalcin interact with calcospherite formation during the calcification process of poly (2-hydroxyethylmethacrylate) in vitro: a Raman microspectroscopic monitoring","volume":"40","author":"Libouban","year":"2009","journal-title":"J Raman Spectrosc"},{"key":"10.1016\/j.morpho.2011.02.004_bib0045","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.morpho.2011.02.004_bib0050","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.morpho.2011.02.004_bib0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.abb.2008.03.027","article-title":"Osteoclast-osteoblast communication","volume":"473","author":"Matsuo","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.morpho.2011.02.004_bib0060","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/nm1514","article-title":"v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation","volume":"12","author":"Lee","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.morpho.2011.02.004_bib0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1242\/jcs.77.1.209","article-title":"An epithelial scatter factor released by embryo fibroblasts","volume":"77","author":"Stoker","year":"1985","journal-title":"J Cell Sci"},{"key":"10.1016\/j.morpho.2011.02.004_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.patbio.2009.11.005","article-title":"Revisiting the canonical tumour progression model","author":"Ansieau","year":"2011","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.morpho.2011.02.004_bib0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10555-007-9066-y","article-title":"Hypoxia: A key regulator of angiogenesis in cancer","volume":"26","author":"Liao","year":"2007","journal-title":"Cancer Metast Rev"},{"key":"10.1016\/j.morpho.2011.02.004_bib0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.med.54.101601.152418","article-title":"Angiogenesis in ischemic and neoplastic disorders","volume":"54","author":"Semenza","year":"2003","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.morpho.2011.02.004_bib0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1056-8719(00)00125-8","article-title":"The vascular system: An overview of structure and function","volume":"44","author":"Pugsley","year":"2000","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.morpho.2011.02.004_bib0090","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the seed and soil\u2019 hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.morpho.2011.02.004_bib0095","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.bjc.6604238","article-title":"Interactions between microenvironment and cancer cells in two animal models of bone metastasis","volume":"98","author":"Blouin","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.morpho.2011.02.004_bib20","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/ar.21150","article-title":"Computed microtomography of bone specimens for rapid analysis of bone changes associated with malignancy","volume":"293","author":"Chappard","year":"2010","journal-title":"Anat Rec"},{"key":"10.1016\/j.morpho.2011.02.004_bib0105","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10585-006-9002-5","article-title":"Rat models of bone metastases","volume":"22","author":"Blouin","year":"2005","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.morpho.2011.02.004_bib0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-005-9120-9","article-title":"Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells","volume":"97","author":"Hiscox","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.morpho.2011.02.004_bib0115","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1089\/152581600750062354","article-title":"Detection of cytokeratin-positive cells in bone marrow in breast cancer and colorectal carcinoma in comparison with other factors of prognosis","volume":"9","author":"Leinung","year":"2000","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1016\/j.morpho.2011.02.004_bib0120","first-page":"3059","article-title":"Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites","volume":"51","author":"Powell","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.morpho.2011.02.004_bib0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000093967","article-title":"Relations between radiograph texture analysis and microcomputed tomography in two rat models of bone metastases","volume":"182","author":"Blouin","year":"2006","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.morpho.2011.02.004_bib0130","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y","article-title":"Molecular mechanisms of osteolytic bone metastases","volume":"88","author":"Guise","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.morpho.2011.02.004_bib0135","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI200422123","article-title":"Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer","volume":"114","author":"Boucharaba","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.morpho.2011.02.004_bib0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/01.blo.0000093055.96273.69","article-title":"Transforming growth factor-beta in osteolytic breast cancer bone metastases","volume":"415S","author":"Guise","year":"2003","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.morpho.2011.02.004_bib0145","first-page":"389","article-title":"Mean osteoplastic surface in zones of plexiform neo-osteogenesis compared with mean osteoplastic surface measured on the fetal bone","volume":"62","author":"Chappard","year":"1978","journal-title":"Bull Assoc Anat (Nancy)"},{"key":"10.1016\/j.morpho.2011.02.004_bib0150","first-page":"185","article-title":"Tumor cells stimulate in vivo periosteal bone formation","volume":"2","author":"Wlodarski","year":"1987","journal-title":"Bone Miner"},{"key":"10.1016\/j.morpho.2011.02.004_bib0155","doi-asserted-by":"crossref","first-page":"S6243","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.morpho.2011.02.004_bib0160","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMra021562","article-title":"Prostate cancer","volume":"349","author":"Nelson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.morpho.2011.02.004_bib0165","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/1541-7786.MCR-07-0117","article-title":"CXCL12\/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone","volume":"6","author":"Chinni","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.morpho.2011.02.004_bib0170","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1349-7006.2008.00833.x","article-title":"CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells","volume":"99","author":"Hu","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.morpho.2011.02.004_bib0175","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/jcb.21835","article-title":"Annexin II\/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer","volume":"105","author":"Shiozawa","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.morpho.2011.02.004_bib0180","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/pros.10022","article-title":"Endothelin-1 production by prostate cancer cell lines is up-regulated by factors involved in cancer progression and down-regulated by androgens","volume":"49","author":"Granchi","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.morpho.2011.02.004_bib0185","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/0006-291X(90)90491-5","article-title":"The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariae","volume":"170","author":"Takuwa","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.morpho.2011.02.004_bib0190","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1054\/bjoc.2000.1261","article-title":"Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption","volume":"83","author":"Chiao","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.morpho.2011.02.004_bib0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10585-005-0056-6","article-title":"Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor","volume":"21","author":"Lu","year":"2004","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.morpho.2011.02.004_bib0200","first-page":"2702","article-title":"Serum interleukin 6 as a prognostic factor in patients with prostate cancer","volume":"6","author":"Nakashima","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.morpho.2011.02.004_bib0205","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0090-4295(01)01405-4","article-title":"Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis","volume":"58","author":"Shariat","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.morpho.2011.02.004_bib0210","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.bbrc.2004.11.162","article-title":"Direct evidence that PTHrP expression promotes prostate cancer progression in bone","volume":"327","author":"Deftos","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.morpho.2011.02.004_bib0215","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S8756-3282(03)00196-0","article-title":"Increased bone remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2 multiple myeloma mouse model","volume":"33","author":"Libouban","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.morpho.2011.02.004_bib0220","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/bcr415","article-title":"Actions of bisphosphonates in animal models of breast cancer","volume":"4","author":"Padalecki","year":"2002","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.morpho.2011.02.004_bib0225","first-page":"S35","article-title":"Dietary calcium deficiency increases osteolysis and modifies gene expression profile in an animal model of multiple myeloma","volume":"82","author":"Libouban","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.morpho.2011.02.004_bib0230","doi-asserted-by":"crossref","first-page":"9542","DOI":"10.1158\/0008-5472.CAN-07-1046","article-title":"Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone","volume":"67","author":"Zheng","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.morpho.2011.02.004_bib0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.morpho.2011.02.004_bib0240","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1359\/jbmr.060118","article-title":"Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac Cdc42, and Rho GTPases","volume":"21","author":"Dunford","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.morpho.2011.02.004_bib0245","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00000421-200212001-00002","article-title":"Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis","volume":"25","author":"Green","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.morpho.2011.02.004_bib0250","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.breast.2007.10.005","article-title":"Bisphosphonates: reducing the risk of skeletal complications from bone metastasis","volume":"16S3","author":"Costa","year":"2007","journal-title":"Breast"},{"key":"10.1016\/j.morpho.2011.02.004_bib0255","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/02841860510029644","article-title":"Skeletal complications of prostate cancer: pathophysiology and therapeutic potential of bisphosphonates","volume":"44","author":"Green","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.morpho.2011.02.004_bib52","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jemt.20814","article-title":"A single pretreatment by zoledronic acid converts metastases from osteolytic to osteoblastic in the rat","volume":"8","author":"Nyangoga","year":"2010","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.morpho.2011.02.004_bib0265","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.morpho.2011.02.004_bib0270","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ejca.2010.02.041","article-title":"Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease","volume":"46","author":"Neville-Webbe","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.morpho.2011.02.004_bib0275","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1158\/1535-7163.MCT-09-0133","article-title":"Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo","volume":"8","author":"Idris","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.morpho.2011.02.004_bib0280","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cbi.2009.09.010","article-title":"Effect of alpha tocopherol acetate in Walker 256\/B cells-induced oxidative damage in a rat model of breast cancer skeletal metastases","volume":"182","author":"Badraoui","year":"2009","journal-title":"Chem Biol Interact"}],"container-title":["Morphologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286011511000208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286011511000208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T13:57:10Z","timestamp":1761141430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286011511000208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":56,"journal-issue":{"issue":"309","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1286011511000208"],"URL":"https:\/\/doi.org\/10.1016\/j.morpho.2011.02.004","relation":{},"ISSN":["1286-0115"],"issn-type":[{"value":"1286-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone metastasis: Histological changes and pathophysiological mechanisms in osteolytic or osteosclerotic localizations. A review","name":"articletitle","label":"Article Title"},{"value":"Morphologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.morpho.2011.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}